354 related articles for article (PubMed ID: 29649374)
1. Precision Therapy of Head and Neck Squamous Cell Carcinoma.
Polverini PJ; D'Silva NJ; Lei YL
J Dent Res; 2018 Jun; 97(6):614-621. PubMed ID: 29649374
[TBL] [Abstract][Full Text] [Related]
2. Leveraging Genomics for Head and Neck Cancer Treatment.
Kemmer JD; Johnson DE; Grandis JR
J Dent Res; 2018 Jun; 97(6):603-613. PubMed ID: 29420101
[TBL] [Abstract][Full Text] [Related]
3. Genomics and precision surgery for head and neck squamous cell carcinoma.
Galmiche A; Saidak Z; Bouaoud J; Mirghani H; Page C; Dakpé S; Clatot F
Cancer Lett; 2020 Jul; 481():45-54. PubMed ID: 32272147
[TBL] [Abstract][Full Text] [Related]
4. Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.
Gong W; Xiao Y; Wei Z; Yuan Y; Qiu M; Sun C; Zeng X; Liang X; Feng M; Chen Q
Oncotarget; 2017 Jan; 8(2):2141-2152. PubMed ID: 27924064
[TBL] [Abstract][Full Text] [Related]
5. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid targeting: towards personalized therapy for head and neck cancer.
Parsel SM; Grandis JR; Thomas SM
Oncogene; 2016 Jun; 35(25):3217-26. PubMed ID: 26592450
[TBL] [Abstract][Full Text] [Related]
7. Molecular Aspects of Head and Neck Cancer Therapy.
Puram SV; Rocco JW
Hematol Oncol Clin North Am; 2015 Dec; 29(6):971-92. PubMed ID: 26568543
[TBL] [Abstract][Full Text] [Related]
8. Research Progress in Head and Neck Squamous Cell Carcinoma: Best Abstracts of ICHNO 2015.
Economopoulou P; Bourhis J; Psyrri A
Am Soc Clin Oncol Educ Book; 2015; ():e323-8. PubMed ID: 25993192
[TBL] [Abstract][Full Text] [Related]
9. Head and Neck Cancer in the New Era of Precision Medicine.
Nör JE; Gutkind JS
J Dent Res; 2018 Jun; 97(6):601-602. PubMed ID: 29771196
[No Abstract] [Full Text] [Related]
10. Current Trends in Precision Medicine and Next-Generation Sequencing in Head and Neck Cancer.
Solis RN; Silverman DA; Birkeland AC
Curr Treat Options Oncol; 2022 Feb; 23(2):254-267. PubMed ID: 35195839
[TBL] [Abstract][Full Text] [Related]
11. Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.
Bowles DW; McDermott JD; Jimeno A
Future Oncol; 2014 May; 10(6):1065-80. PubMed ID: 24941990
[TBL] [Abstract][Full Text] [Related]
12. Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.
Mes SW; Leemans CR; Brakenhoff RH
Expert Rev Mol Diagn; 2016; 16(2):205-21. PubMed ID: 26620464
[TBL] [Abstract][Full Text] [Related]
13. Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
Hanna GJ; Adkins DR; Zolkind P; Uppaluri R
Oral Oncol; 2017 Oct; 73():65-69. PubMed ID: 28939078
[TBL] [Abstract][Full Text] [Related]
14. Genomic sequencing and precision medicine in head and neck cancers.
Hoesli RC; Ludwig ML; Michmerhuizen NL; Rosko AJ; Spector ME; Brenner JC; Birkeland AC
Eur J Surg Oncol; 2017 May; 43(5):884-892. PubMed ID: 28034498
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.
Schmitz S; Machiels JP
Curr Treat Options Oncol; 2016 Jul; 17(7):37. PubMed ID: 27262711
[TBL] [Abstract][Full Text] [Related]
16. Precision medicine in head and neck cancer.
Kaidar-Person O; Gil Z; Billan S
Drug Resist Updat; 2018 Sep; 40():13-16. PubMed ID: 30466712
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in early diagnosis of head and neck cancer in precision medicine era].
Min MK; Zhu MH; Zheng HL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(22):1770-1774. PubMed ID: 29798197
[TBL] [Abstract][Full Text] [Related]
18. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
19. Molecularly targeted agents and immunotherapy for the treatment of head and neck squamous cell cancer (HNSCC).
Azoury SC; Gilmore RC; Shukla V
Discov Med; 2016 Jun; 21(118):507-16. PubMed ID: 27448787
[TBL] [Abstract][Full Text] [Related]
20. The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.
Pryor DI; Solomon B; Porceddu SV
Asia Pac J Clin Oncol; 2011 Sep; 7(3):236-51. PubMed ID: 21884435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
